Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Otsuka Holdings Co Ltd (JP:4578)
TSE/TYO:4578
Holding JP:4578?
Track your performance easily
4578 Stock Chart & Stats
Day’s Range¥0 - ¥0
52-Week Range¥5,030.00 - ¥9,669.00
Previous Close¥9,498
Volume1.34M
Average Volume (3M)1.26M
Market Cap
¥5.15T
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)34.0
Beta0.75
Next Earnings
Feb 12, 2025EPS Estimate
¥60.46Next Dividend Ex-Date
Dec 27, 2024Dividend Yield1.28%
Share Statistics
EPS (TTM)279.46
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,257,810
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥10,306.47Price Target Upside8.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Otsuka Holdings Co News
PremiumCompany Announcements
Otsuka Holdings Reports Strong Nine-Month Financial Growth
PremiumCompany Announcements
Otsuka Holdings Co. Announces Leadership Transition
PremiumCompany Announcements
Otsuka’s Promising Drug Advances in Kidney Disease TrialPremiumCompany Announcements
Otsuka Holdings Conducts Multi-Billion Yen Share Buyback
PremiumCompany Announcements
Otsuka Holdings Reports Shift in Major Shareholders
PremiumCompany Announcements
Otsuka’s Rexulti Gains New Approval in Japan
PremiumCompany Announcements
Otsuka Holdings Completes Multi-Billion Yen Share BuybackPremiumCompany Announcements
Otsuka Holdings Expands R&D with Jnana AcquisitionOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.05% Mutual Funds
0.28% Other Institutional Investors
85.66% Public Companies and
Individual Investors
4578 FAQ
What was Otsuka Holdings Co Ltd’s price range in the past 12 months?
Otsuka Holdings Co Ltd lowest stock price was ¥5030.00 and its highest was ¥9669.00 in the past 12 months.
What is Otsuka Holdings Co Ltd’s market cap?
Currently, no data Available
When is Otsuka Holdings Co Ltd’s upcoming earnings report date?
Otsuka Holdings Co Ltd’s upcoming earnings report date is Feb 12, 2025 which is in 94 days.
How were Otsuka Holdings Co Ltd’s earnings last quarter?
Otsuka Holdings Co Ltd released its earnings results on Oct 31, 2024. The company reported ¥154.72 earnings per share for the quarter, missing the consensus estimate of ¥186.72 by -¥32.
Is Otsuka Holdings Co Ltd overvalued?
According to Wall Street analysts Otsuka Holdings Co Ltd’s price is currently Undervalued.
Does Otsuka Holdings Co Ltd pay dividends?
Otsuka Holdings Co Ltd pays a Annually dividend of ¥60 which represents an annual dividend yield of 1.28%. See more information on Otsuka Holdings Co Ltd dividends here
What is Otsuka Holdings Co Ltd’s EPS estimate?
Otsuka Holdings Co Ltd’s EPS estimate is ¥60.46.
How many shares outstanding does Otsuka Holdings Co Ltd have?
Otsuka Holdings Co Ltd has 557,835,630 shares outstanding.
What happened to Otsuka Holdings Co Ltd’s price movement after its last earnings report?
Otsuka Holdings Co Ltd reported an EPS of ¥154.72 in its last earnings report, missing expectations of ¥186.72. Following the earnings report the stock price went up 1.234%.
Which hedge fund is a major shareholder of Otsuka Holdings Co Ltd?
Currently, no hedge funds are holding shares in JP:4578
---
Otsuka Holdings Co Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
71.15%
12-Months-Change
Fundamentals
Return on Equity
5.89%
Trailing 12-Months
Asset Growth
9.81%
Trailing 12-Months
Company Description
Otsuka Holdings Co Ltd
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded on July 8, 2008 and is headquartered in Tokyo, Japan.
---
4578 Stock 12 Month Forecast
Average Price Target
¥10,306.47
▲(8.51% Upside)
Technical Analysis
Best Analysts Covering 4578
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+28.30%
reiterated a buy rating 9 days ago
Copying Akinori Ueda's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +28.30% per trade.
---